Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
出版年份 2022 全文链接
标题
Estrogen Receptor-Beta2 (ERβ2)–Mutant p53–FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC)
作者
关键词
-
出版物
Cancers
Volume 14, Issue 5, Pages 1120
出版商
MDPI AG
发表日期
2022-02-23
DOI
10.3390/cancers14051120
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis
- (2021) Jie Mei et al. CELL PROLIFERATION
- Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
- (2021) Aya Saleh et al. Cancers
- Estrogen Signaling and Its Potential as a Target for Therapy in Ovarian Cancer
- (2020) Simon P. Langdon et al. Cancers
- Estrogen Receptor-β Expression of Ovarian Tumors and Its Association with Ovarian Cancer Risk Factors
- (2020) Amy L. Shafrir et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer
- (2019) Utpal K Mukhopadhyay et al. JNCI-Journal of the National Cancer Institute
- Clinical relevance of TP53 hotspot mutations in high-grade serous ovarian cancers
- (2019) Musaffe Tuna et al. BRITISH JOURNAL OF CANCER
- Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
- (2019) Shuang Zhang et al. Nature Communications
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- New therapeutic strategies to treat human cancers expressing mutant p53 proteins
- (2018) Giovanni Blandino et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting estrogen receptor beta (ERβ) for treatment of ovarian cancer: importance of KDM6B and SIRT1 for ERβ expression and functionality
- (2018) Giulia Pinton et al. Oncogenesis
- Cell Origins of High-Grade Serous Ovarian Cancer
- (2018) Jaeyeon Kim et al. Cancers
- Serous tubal intraepithelial neoplasia: the concept and its application
- (2017) Emily E K Meserve et al. MODERN PATHOLOGY
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
- (2017) Jinyou Liu et al. Oncotarget
- Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy
- (2016) Ioannis Kyriakidis et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones
- (2016) Yi A. Ren et al. CANCER RESEARCH
- ERβ decreases the invasiveness of triple-negative breast cancer cells by regulating mutant p53 oncogenic function
- (2016) Igor Bado et al. Oncotarget
- TP53Mutations in Breast and Ovarian Cancer
- (2016) Laxmi Silwal-Pandit et al. Cold Spring Harbor Perspectives in Medicine
- Hormone receptors as a marker of poor survival in epithelial ovarian cancer
- (2015) Michel van Kruchten et al. GYNECOLOGIC ONCOLOGY
- Mitochondrial estrogen receptor β2 drives antiapoptotic pathways in advanced serous ovarian cancer
- (2015) Alessandra Ciucci et al. HUMAN PATHOLOGY
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- FOXM1: An emerging master regulator of DNA damage response and genotoxic agent resistance
- (2014) Stefania Zona et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma
- (2014) Koji Matsuo et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of the estrogen receptor beta (ERβ) isoforms ERβ1, ERβ2, and ERβ5 in advanced serous ovarian cancer
- (2014) Alessandra Ciucci et al. GYNECOLOGIC ONCOLOGY
- TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
- (2014) PAVLA BRACHOVA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer
- (2014) Jennifer R. Ribeiro et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer
- (2013) Stefanie Aust et al. BMC CANCER
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Negative Regulation of Estrogen Signaling by ERβ and RIP140 in Ovarian Cancer Cells
- (2013) Aurélie Docquier et al. MOLECULAR ENDOCRINOLOGY
- Clinical Relevance of Gain-Of-Function Mutations of p53 in High-Grade Serous Ovarian Carcinoma
- (2013) Hyo Jeong Kang et al. PLoS One
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Role of estrogen receptor β in gynecological cancer
- (2012) Julia Häring et al. GYNECOLOGIC ONCOLOGY
- Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
- (2012) Carine Bossard et al. PLoS One
- Ovarian Actions of Estrogen Receptor-β: An Update
- (2012) Ann Drummond et al. SEMINARS IN REPRODUCTIVE MEDICINE
- Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer
- (2011) Ilaria De Stefano et al. GYNECOLOGIC ONCOLOGY
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
- (2011) J. Millour et al. MOLECULAR CANCER THERAPEUTICS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- p53 negatively regulates expression of FoxM1
- (2010) Bulbul Pandit et al. CELL CYCLE
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- Estrogen Receptor Subtypes in Ovarian Cancer
- (2010) Karen K. L. Chan et al. OBSTETRICS AND GYNECOLOGY
- Pro-proliferative FoxM1 is a target of p53-mediated repression
- (2009) A M Barsotti et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search